Your browser doesn't support javascript.
loading
Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): a protocol for a randomised controlled trial.
Velen, Kavindhran; Nguyen, Viet Nhung; Nguyen, Binh Hoa; Dang, Tho; Nguyen, Hoang Anh; Vu, Dinh Hoa; Do, Thu Thuong; Pham Duc, Cuong; Nguyen, Huu Lan; Pham, Huu Thuong; Marais, Ben J; Johnston, James; Britton, Warwick; Beardsley, Justin; Negin, Joel; Wiseman, Virginia; Marks, Guy Barrington; Nguyen, Thu Anh; Fox, Greg J.
Afiliação
  • Velen K; Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia Kavi.velen@sydney.edu.au.
  • Nguyen VN; The National Lung Hospital, Hanoi, Vietnam.
  • Nguyen BH; The National Lung Hospital, Hanoi, Vietnam.
  • Dang T; Woolcock Institute of Medical Research, Glebe, New South Wales, Australia.
  • Nguyen HA; National Drug Information and Adverse Drug Reaction Monitoring Centre, Hanoi, Vietnam.
  • Vu DH; National Drug Information and Adverse Drug Reaction Monitoring Centre, Hanoi, Vietnam.
  • Do TT; The National Lung Hospital, Hanoi, Vietnam.
  • Pham Duc C; Woolcock Institute of Medical Research, Glebe, New South Wales, Australia.
  • Nguyen HL; Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam.
  • Pham HT; Hanoi Lung Hospital, Hanoi, Vietnam.
  • Marais BJ; Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
  • Johnston J; BCCDC, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.
  • Britton W; Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney, Sydney, New South Wales, Australia.
  • Beardsley J; Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Negin J; Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
  • Wiseman V; School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Marks GB; School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Nguyen TA; Health Economics, LSHTM, London, UK.
  • Fox GJ; Woolcock Institute of Medical Research, Camperdown, New South Wales, Australia.
BMJ Open ; 12(6): e052633, 2022 06 22.
Article em En | MEDLINE | ID: mdl-35732397

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Tuberculose Resistente a Múltiplos Medicamentos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Tuberculose Resistente a Múltiplos Medicamentos Idioma: En Ano de publicação: 2022 Tipo de documento: Article